Medicine: Defence against anthrax

The use of anthrax spores as a biological weapon has inevitably increased interest in compounds that can counter the threat. PlyG lysin, isolated from the γ phage of Bacillus anthracis, is a strong candidate. PlyG specifically kills B. anthracis bacilli and germinating spores in vitro and in vivo. In the cover image, cell wall breakdown has caused the cytoplasmic membrane to externalize (shown circled) prior to cell lysis. The lytic specificity of PlyG can also be exploited as part of a rapid method for the identification of B. anthracis.

A bacteriolytic agent that detects and kills Bacillus anthracis
RAYMOND SCHUCH, DANIEL NELSON & VINCENT A. FISCHETTI
Nature 418, 884–889 (2002); doi:10.1038/nature01026
| First Paragraph | Full Text (HTML / PDF) |

Medicine: Virus deals anthrax a killer blow
M. J. ROSOVITZ & STEPHEN H. LEPPLA
The threat of antibiotic-resistant bacteria is driving researchers to think up ever more clever ways to tackle infections. An enzyme from a bacterium-killing virus may prove effective against anthrax infections.
Nature 418, 825–826 (2002); doi:10.1038/418825a
| Full Text (HTML / PDF) |

Anthrax case provokes doubt among experts
JONATHAN KNIGHT & ERIKA CHECK
Nature 418, 808 (2002); doi:10.1038/418808a
| Full Text (HTML / PDF) |

Anthrax exposed and killed

22 August 2002 table of contents

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.